EDITAS MEDICINE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
EDITAS MEDICINE, INC. (EDIT) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value of $24.20 per share as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2019-11-12
- 2019-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $24.20.
- 2019-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $24.11.
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $24.06.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $28.05.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value |
|---|---|
| 2019-09-30 | $24.20 10-Q · filed 2019-11-12 |
| 2019-06-30 | $24.11 10-Q · filed 2019-08-07 |
| 2019-03-31 | $24.06 10-Q · filed 2019-05-08 |
| 2018-12-31 | $28.05 10-Q · filed 2019-11-12 |
| 2018-09-30 | $28.05 10-Q · filed 2018-11-08 |
| 2018-06-30 | $28.05 10-Q · filed 2018-08-07 |
| 2018-03-31 | $22.22 10-Q · filed 2018-05-04 |
| 2017-12-31 | $18.70 10-Q · filed 2018-11-08 |
| 2017-09-30 | $0.03 10-Q · filed 2017-11-08 |
| 2017-06-30 | $0.03 10-Q · filed 2017-08-09 |
| 2017-03-31 | $0.02 10-Q · filed 2017-05-15 |
| 2016-12-31 | $0.02 10-Q · filed 2017-11-08 |
| 2016-09-30 | $0.02 10-Q · filed 2016-11-09 |
| 2016-06-30 | $0.02 10-Q · filed 2016-08-10 |
| 2016-03-31 | $0.02 10-Q · filed 2016-05-13 |
| 2015-12-31 | $0.02 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |